Dr. James McCracken is Joseph Campbell Professor of Child Psychiatry at UCLA School of Medicine and also is Director of the Division of Child and Adolescent Psychiatry at the UCLA Neuropsychiatric Institute. He is a member of many professional societies including the American Academy of Child and Adolescent Psychiatry, the Society of Biological Psychiatry, and the Society for Neuroscience. He has published widely in the area of child psychiatry and recently served as an Associate Editor for the Textbook of Pediatric Neuropsychiatry. Dr. McCracken has been the recipient of various honors and awards including the 1992 American Psychiatric Association’s Young Psychiatrist Research Award and a Physician Scientist Award from NIMH in 1980. Dr. McCracken's current areas of research include the testing of new pharmacological treatments for a variety of child neuropsychiatric disorders, including autism, attention deficit hyperactivity disorder, obsessive compulsive disorder, and anxiety disorders. He has been the Principal Investigator (PI) of the ULCA Research Unit on Pediatric Psychopharmacology (RUPP) since its inception in 1997 and was PI of the UCLA site for the RUPP Risperidone Study and the RUPP Multisite Anxiety Study. He recently expanded his research into testing the role of genes as predictors of drug response and adverse events (with a K24 Award from NIMH). Dr. McCracken received medical and postgraduate training at Baylor College of Medicine, Duke University, and UCLA before joining the UCLA faculty in 1987.